• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom

FDA NEWS RELEASE

FOR IMMEDIATE RELEASE
P06-151
September 29, 2006

Media Inquiries:
Megan Moynahan, 301-827-6242
Consumer Inquiries:
888-INFO-FDA


 

FDA Approves Treatment for Nerve-Poisoning Agents for Use by Trained Emergency Medical Services Personnel

The U.S. Food and Drug Administration (FDA) today approved Duodote (atropine and pralidoxime chloride injection) for use by trained emergency medical services personnel to treat civilians exposed to life-threatening organophosphorus-containing nerve agents, such as sarin, and insecticides.  Duodote is manufactured by Meridian Medical Technologies, Inc., Columbia, Md.

FDA previously approved atropine and pralidoxime chloride injection under the name Antidote Treatment--Nerve Agent Auto-Injector (ATNAA) for military use.  Developed by the U.S. Army and manufactured by Meridian Medical Technologies, Inc., ATNAA is not available for use in civilians.  ATNAA was approved on Jan. 17, 2002, for use by the military to treat troops who have been exposed to toxic nerve agents that cause loss of muscle control and death from respiratory failure.  The two constituent drugs in ATNAA were previously approved for use separately.  Atropine autoinjector has been approved for use in adults since 1973, and its use in children and adolescents was approved in June 2003.  Pralidoxime was first approved for use in 1964.

"Today's approval facilitates the stockpiling of the product so that it can be used to treat civilians in an emergency," said Douglas Throckmorton, M.D., deputy director of FDA's Center for Drug Evaluation and Research. "The approval contains two caveats: the primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective clothing; and Duodote may be administered only by well-trained emergency medical personnel."

The manufacturer will distribute Duodote directly to emergency medical service organizations or their suppliers.

#
 

RSS Feed for FDA News Releases [what is RSS?]